European Child Receives Strimvelis Gene-Therapy Treatment – Rare Disease Report
|
European Child Receives Strimvelis Gene–Therapy Treatment
Rare Disease Report The drug can revise a patient's genetic makeup, and while gene therapy has been widely explored in studies, its commercial potential has gone unproven due to difficulty organizing cross-border reimbursement. Currently, Strimvelis is offered at a single … |
